CXCR3-B Can Mediate Growth-inhibitory Signals in Human Renal Cancer Cells by Down-regulating the Expression of Heme Oxygenase-1

Therapeutic strategies by modulating oxygen stress in cancer and inflammation

(2009) Jun Fang et al.   ADVANCED DRUG DELIVERY REVIEWS

A Novel Experimental Heme Oxygenase-1-Targeted Therapy for Hormone-Refractory Prostate Cancer

(2009) M. A. Alaoui-Jamali et al.   CANCER RESEARCH

Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease

(2009) Danielle Morse et al.   FREE RADICAL BIOLOGY AND MEDICINE

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

(2009) X. Ma et al.   MOLECULAR CANCER THERAPEUTICS

Activation of p38MAPK mediates the angiostatic effect of the chemokine receptor CXCR3-B

(2008) Ilaria Petrai et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice

(2008) Gabriele Sass et al.   INTERNATIONAL JOURNAL OF CANCER

Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer Progression

(2008) D. Datta et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY